New hair loss gel enters first human safety tests
NCT ID NCT06927960
Summary
This early-stage study tested a new topical gel called AH-001 for male pattern baldness. The main goal was to check its safety and how the body absorbs it. Researchers tested different strengths on healthy volunteers and men with hair loss to see how well it was tolerated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences Clinical Los Angeles, Inc.
Los Angeles, California, 90630, United States
Conditions
Explore the condition pages connected to this study.